A study on QT interval in patients affected with inflammatory bowel disease without cardiac involvement.
Cardiac involvement has been studied quite extensively in patients affected by inflammatory bowel disease but, as of now, there is no data regarding QT alterations which are well known to be linked to the risk of dangerous arrhythmias. In this study, QT parameters were digitally measured on standard 12-lead ECG in a population of 20 patients affected by inflammatory bowel disease (IBD), with no prior (recent or old) history of cardiac disease and no evidence of electrolyte imbalance. Eighteen healthy subjects formed the control group. The results obtained using non-parametric statistics (Wilcoxon-Mann-Whitney test) showed that heart rate corrected QT interval (QTc) and QTc dispersion (QTc d) values were both significantly higher in IBD patients than in the control group. QTc rank sum values in patients affected by inflammatory bowel disease were 469 versus 311 in healthy subjects (Z = 1.939, p = 0.0263). QTc d rank sum values were 460 in IBD patients versus 320 in controls (Z = 1.686 with p = 0.0459). Regardless of the cause of these QT alterations, it appears evident that accurate monitoring of QT parameters is required in these patients who often experience electrolyte disturbances and who may, in some cases, be undergoing treatment with potentially cardiotoxic drugs such as infliximab.
Curione
Mario
M
Department of Clinical Sciences, Policlinico Umberto I, University La Sapienza of Rome, Viale del Policlinico 155, Rome, Italy. mario.curione@uniroma1.it
Aratari
Annalisa
A
Amato
Silvia
S
Colotto
Marco
M
Barbato
Maria
M
Leone
Silvia
S
Tego
Andi
A
Panetti
Diego
D
Parlapiano
Claudio
C
D001145:Arrhythmias, Cardiac / Q000150:complications*; D004562:Electrocardiography; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications*; D008133:Long QT Syndrome / Q000150:complications*
Med Klin (Munich). 2006 Mar 22;101 Suppl 1:56-60
16802521
Am Heart J. 1989 Jul;118(1):174-6
2741785
Ann Intern Med. 2003 May 20;138(10):807-11
12755552
Int J Colorectal Dis. 2007 Sep;22(9):1123-5
17541784
Z Gastroenterol. 1996 Jan;34(1):27-9
8776172
Inflamm Bowel Dis. 2010 Mar;16(3):373-4
19639557
Eur J Clin Pharmacol. 2007 Sep;63(9):875-8
17598094
Intern Med J. 2008 Nov;38(11):865-7
19120538
World J Gastroenterol. 2006 Aug 14;12(30):4819-31
16937463
Heart Rhythm. 2005 Apr;2(4):357-64
15851335
Compr Ther. 2008 Summer;34(2):111-4
18833788
Schweiz Med Wochenschr. 1997 May 31;127(22):935-9
9289821
J Diabetes Complications. 2003 Jul-Aug;17(4):169-78
12810239
Expert Opin Drug Saf. 2008 Sep;7(5):617-32
18759714
Dan Med Bull. 1997 Sep;44(4):442-4
9377906
Eur Heart J. 1998 Sep;19(9):1279-81
9792252
Am J Gastroenterol. 2007 Jan;102(1):217-9
17278277
J Intern Med. 2003 Mar;253(3):386-8
12603508
J Am Soc Echocardiogr. 2004 Oct;17(10):1086-119
15452478
Schweiz Med Wochenschr. 1996 Dec 14;126(50):2184-90
9005529
Gut. 1992 Oct;33(10):1427-9
1446875